Participated · Equity · Feb 2026

Medikabazaar operates a technology-driven B2B e-commerce platform that streamlines procurement of medical equipment and consumables for healthcare providers. The company has recently completed an operational reset that emphasized supply–chain integration and customer experience, helping revenues surpass ₹2,000 crore while achieving operating breakeven and a profitable EBITDA. Its marketplace shows consistent double-digit year-on-year growth, supported by deeper supplier partnerships and improved platform capabilities. Management plans to channel new capital into accelerating digital innovation, reinforcing category leadership, upgrading technology infrastructure, and widening its pan-India footprint. Positioned within an Indian healthcare sector forecast to reach $320 billion by FY28, Medikabazaar benefits from rising hospital capacity and a broader shift toward digital procurement. With an eye on becoming an "ecosystem orchestrator" for healthcare supply chains, the firm aims to capture value from trends such as platform consolidation and actionable AI.

Participated · Series A · Jan 2026

Nivaan Care offers a specialized healthcare platform that combines interventional pain management, physiotherapy, and coordinated patient support to create a standardized care pathway for chronic pain sufferers. The company differentiates itself from generalist settings through a clinician-centric, outcomes-measured approach intended to deliver consistent improvements for patients. By centralizing diagnosis, treatment, and follow-up, Nivaan aims to address the fragmented access that affects an estimated 270 million Indians living with chronic pain. Investor commentary highlights the team’s clinical depth and its ability to scale specialty care without sacrificing quality. With fresh capital, the company plans to accelerate national expansion, open additional locations, and deepen its platform capabilities to make specialist pain care more accessible and repeatable. Although specific revenue or user metrics were not disclosed, the sizable market opportunity and operational focus have attracted multiple healthcare-focused investors.

Participated · Series B · Dec 2025

Founded in 2018, Virohan provides a technology-enabled platform that designs and delivers undergraduate programs in Optometry, Medical Lab Technology, Operation Theatre Technology, Physiotherapy, Radiology and related fields. The company collaborates with universities across India to ensure curricula are aligned with industry requirements, aiming to bridge the shortage of skilled allied healthcare professionals. Virohan’s software-driven approach focuses on standardized content, digital assessments and analytics to improve learning outcomes and employability. Looking ahead, the company targets impacting one million aspiring healthcare professionals and partnering with more than 100 universities by 2030. The newly secured capital will be allocated toward product innovation, operational efficiency improvements, and talent acquisition, all intended to accelerate the path to profitability. Although revenue or user numbers were not disclosed, management emphasizes scalability through university partnerships and curriculum expansion.

Led · Series B · Sep 2025

Dat Bike designs and produces electric motorbikes for the mass Vietnamese two-wheeler market, which counts more than 77 million bikes in circulation and around 3 million new sales each year. The company positions its models as locally built, high-performance alternatives to gasoline motorcycles. Fresh capital is being channelled into scaling production capacity, improving its supply chain, upgrading distribution networks, and deepening R&D. Management consulting and value-chain optimisation support are also being provided by its latest investor, Thien Viet Securities (TVS). Dat Bike previously secured a US$22 million Series B round in 2023, with regulatory filings indicating US$33.9 million in total that year when debt and convertible notes are included. Past backers include F.C.C Co. Ltd., Rebright Partners, Jungle Ventures, Cathay Venture, TVS Motor, Wavemaker Pacific, and AiViet Ventures. The additional funds position Dat Bike to capture a larger share of Vietnam’s rapidly electrifying mobility sector.

Participated · Series A · Apr 2025

Stimuler is a Bengaluru, India-based, voice-first AI tutor focused on helping English-as-a-second-language users improve spoken English. Led by CEO Akshay Akash, the product leverages advanced speech analysis and AI-driven learning to focus on how people learn and practice spoken English. The company reports over 4 million app installs and more than 45,000 paying users across Android and iOS. The majority of its paying user base is outside India, with adoption in Latin America and Southeast Asia, particularly Indonesia. Stimuler says it will use the funds to expand its AI capabilities, grow its technical team, and drive growth in global markets. Stimuler is a Lucknow, Uttar Pradesh–based voice AI platform focused on helping non-native speakers master conversational English. Its product analyzes speech patterns and provides real-time feedback to create an interactive language-learning environment. The company leverages artificial intelligence to offer engaging practice aimed at improving spoken English fluency. Stimuler raised $1 million in a seed funding round, bringing total funding to $1,025,000 across two rounds. The startup says the new capital will fuel growth, expansion, and continued refinement of its platform to reach more learners. Reporting positions Stimuler as an emerging player in Lucknow’s technology scene and the wider internet industry.